OMI Owens & Minor

Owens & Minor, Inc. is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Its Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.

Company profile

Edward Pesicka
Fiscal year end
Former names
IRS number

OMI stock data



3 Aug 21
4 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 61.75M 61.75M 61.75M 61.75M 61.75M 61.75M
Cash burn (monthly) 3.01M 11.23M (positive/no burn) (positive/no burn) 4.34M (positive/no burn)
Cash used (since last report) 3.52M 13.14M n/a n/a 5.08M n/a
Cash remaining 58.22M 48.6M n/a n/a 56.67M n/a
Runway (months of cash) 19.3 4.3 n/a n/a 13.1 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jun 21 Beck Mark A Phantom Stock Common Stock Grant Aquire A No No 42.33 7 296.31 44,406
30 Jun 21 Mark F Mcgettrick Phantom Stock Common Stock Grant Aquire A No No 42.33 11 465.63 112,812
30 Jun 21 Robert J Henkel Phantom Stock Common Stock Grant Aquire A No No 42.33 7 296.31 41,361
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 48.356 19,428 939.46K 242,974
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 47.244 17,832 842.46K 262,402
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 46.623 6,440 300.25K 280,234
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 45.152 2,300 103.85K 286,674
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 43.816 4,100 179.65K 288,974
7 Jun 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 43.059 1,900 81.81K 293,074
4 Jun 21 Zacur Mark P Common Stock Sell Dispose S No Yes 42.42 12,746 540.69K 71,769

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

87.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 251 234 +7.3%
Opened positions 52 65 -20.0%
Closed positions 35 38 -7.9%
Increased positions 77 72 +6.9%
Reduced positions 83 72 +15.3%
13F shares
Current Prev Q Change
Total value 9.98B 1.76B +468.4%
Total shares 65.75M 64.85M +1.4%
Total puts 628.5K 369.8K +70.0%
Total calls 500.4K 699.4K -28.5%
Total put/call ratio 1.3 0.5 +137.5%
Largest owners
Shares Value Change
BLK Blackrock 12.3M $462.26M +8.0%
Vanguard 6.33M $237.83M +6.9%
Dimensional Fund Advisors 3.86M $145.26M -11.8%
Wellington Management 3.12M $117.22M +4.5%
FMR 2.62M $98.52M -18.9%
STT State Street 2.41M $90.45M -7.6%
Renaissance Technologies 2.37M $88.96M -23.2%
WFC Wells Fargo & Co. 2.36M $88.9M +166.0%
Deerfield Management 1.55M $58.23M +41.3%
D. E. Shaw & Co. 1.35M $50.89M +90.5%
Largest transactions
Shares Bought/sold Change
WFC Wells Fargo & Co. 2.36M +1.48M +166.0%
Citadel Advisors 466.68K -1.08M -69.9%
BLK Blackrock 12.3M +912.05K +8.0%
Eagle Asset Management 898.96K +898.96K NEW
Renaissance Technologies 2.37M -714K -23.2%
D. E. Shaw & Co. 1.35M +643.21K +90.5%
FMR 2.62M -611.59K -18.9%
Charles Schwab Investment Management 1.28M +586.48K +84.0%
Dimensional Fund Advisors 3.86M -517.55K -11.8%
Iron Triangle Partners 0 -454.42K EXIT

Financial report summary

  • We face competition and accelerating pricing pressure.
  • Our operating income is dependent on certain significant domestic suppliers.
  • An inability to obtain key components, raw materials or manufactured products from third parties may have a material adverse effect on our Global Products segment.
  • Our results of operations may suffer upon the bankruptcy, insolvency, or other credit failure of a customer that has a substantial amount owed to us.
  • Changing conditions in the United States healthcare industry may impact our results of operations.
  • We may not be able to refinance, extend or repay our substantial indebtedness which would have a material adverse affect on our financial condition.
  • Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
  • Our credit facilities and our existing notes have restrictive covenants that could limit our financial flexibility.
  • We may incur product liability losses, litigation liability, product recalls, safety alerts or regulatory action associated with the products that we source, assemble, manufacture and sell which can be costly and disruptive to our business.
  • We must obtain clearance or approval from the appropriate regulatory authorities prior to introducing a new product or a modification to an existing product. The regulatory clearance process may result in substantial costs, delays and limitations on the types and uses of products we can bring to market, any of which could have a material adverse effect on our business.
  • Our business may be adversely affected if we are unable to adequately establish, maintain, protect and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of such rights.
  • We may become subject to litigation brought by third parties claiming infringement, misappropriation or other violation by us of their intellectual property rights.
  • Our business and operations depend on the proper functioning of critical facilities, supply chain and distribution networks.
  • We are subject to stringent regulatory and licensing requirements.
  • Compliance with the terms and conditions of Byram’s Corporate Integrity Agreement requires significant resources and, if we fail to comply, we could be subject to penalties or excluded from participation in government healthcare programs, which could seriously harm our results of operations, liquidity and financial condition.
  • General economic conditions may adversely affect demand for our products and services.
  • Our continued success is substantially dependent on positive perceptions of our reputation.
  • Our inability to adequately integrate acquisitions could have a material adverse effect on our operations.
  • Our ability to attract and retain talented and qualified teammates is critical to our success and competitiveness.
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading global healthcare solutions company. On June 18, 2020 (the Divestiture Date), we completed the divestiture of our European logistics business, Movianto (the Divestiture), as well as certain support functions in our Dublin, Ireland office, to Walden Group SAS (the Buyer) and EHDH (as Buyer’s guarantor) for cash consideration of $133 million. The Divestiture provides us with a greater ability to focus on and invest in our differentiated products, services and U.S. distribution businesses.
  • As a result of the Divestiture, the results of operations from our Movianto business are reported as “Loss from discontinued operations, net of tax” for the three and six months ended June 30, 2020. See Note 3, “Discontinued Operations,” of the Notes to Consolidated Financial Statements for further information. Unless otherwise indicated, the following information relates to continuing operations.
Content analysis
H.S. sophomore Good
New words: aforementioned, analyzing, attempted, chain, concurrent, confidential, contemplate, coupled, customary, cyberattack, cybersecurity, elevated, Essential, experience, external, factor, failure, filling, functioning, glove, hosting, incident, insertion, malware, millon, processing, proper, properly, proprietary, public, ransomware, recovery, relied, rely, reputation, sensitive, sophisticated, storage, tampering, technical, transmission, transportation, Travel, unauthorized, variant, world
Removed: Advanced, Base, estate, Eurocurrency, filed, independent, Interbank, London, real